Treatment of experimental periodontal disease by laser therapy in simvastatin-modified rats Low intensity laser can be used as a promising alternative in the treatment of periodontal disease. Objective: The aim of this study was to evaluate low-level laser therapy (LLLT) as an adjuvant treatment for scaling and root Within the limits of this study, we can conclude that LLLT was effective as adjuvant treatment for SRP protecting against the occurrence of oxidative tissue damages as well as for reducing alveolar bone loss in experimentally induced periodontitis simvastatin-modified rats.
There is evidence of a more aggressive destruction of tooth support tissues with elevated levels of oxidative stress markers during the development of periodontal disease (PD) 24 . Among the oxidants, the superoxide anion 9 , in periodontal tissues, can be involved in signaling of induction of bone resorption;
the hydroxyl radical 12 is extremely reactive and can damage important biomolecules, such as proteins, lipids and nucleic acids, whereas hydrogen peroxide is able to cross membranes, damaging adjacent cells and increasing the oxidative cascade 28 .
Thus, most studies demonstrate that periodontitis is associated with increased lipid peroxidation 29 and increased protein carbonyls 9 as well as decreased antioxidants, such as reduced glutathione (GSH) 11,29. In addition, there are evidences of decreased oxidative injuries and changes in antioxidant system following periodontal treatment 19 .
The treatment of PD is based on the elimination of pathogenic subgingival microbiota by scaling and root planing (SRP) 24 . However, mechanical therapy used alone may be defective in the elimination of pathogenic bacteria, since they are located within soft and hard tissues or in areas that are inaccessible to periodontal Simvastatin is an inhibitor of the 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG -CoA reductase) enzyme, which is responsible for the synthesis of cholesterol and therefore it is widely used for the systemic treatment of diseases related to hypercholesterolemia. This drug also has antiinflammatory, immunomodulator, antioxidant, and angiogenic effects 6, 25 , and it also promotes increased osteoblast formation 10, 20 . Induction of experimental periodontal disease (Table 1) .
Expression of MDA in gingival samples
In the intragroup comparison, levels of MDA in LLLT decreased significantly (p<0.05) compared with NT, in the S group in all experimental periods, and in the Veh group at 7 and 30 days.
In the comparison between the groups (Veh and S), among the same local treatments, MDA levels in S group were significantly lower than those in Veh group (p<0.05), for NT, SRP and LLLT at 7 days ( Table 2) . 
Expression of CP in gingival samples
In the intragroup comparison (Veh and S), levels of CP in LLLT decreased significantly (p<0.05) in relation to NT in all the experimental periods.
In the comparison between Veh and S groups, among the same local treatments, CP levels in the S group were significantly lower than those in the Veh group (p<0.05), for NT, SRP and LLLT at 7 days. In addition, CP levels in the Veh group, treated by LLLT, were significantly lower than those in the S group (p<0.05), which did not receive local treatment (NT) at 7 and 15 days (Table 3) .
Radiographic analysis
In the intragroup analysis between Veh and S, LLLT showed lower BL compared with NT and SRP, in all experimental periods (p<0.01).
In the intergroup analysis between the same local treatments, the SRP presented a lower BL (p<0.01) in and gingival tissue 11, 28 . In the intragroup comparison we observed that levels of MDA in NT were significantly higher (p<0.05) compared with LLLT, in the S group in all experimental periods, and in the Veh group at 7 and 30 days. These results demonstrate that MDA is a good marker of oxidative stress. Our results corroborate other studies 11, 23 , which report that lipid peroxidation is a very common example of oxidative stress in induced periodontitis and that its increase plays an important 15, 30 . Whereas regarding LLLT, it was observed that it inhibited the production of inflammatory mediators However, in a meta-analysis study 23 , the results showed no difference when comparing the treatment of periodontal disease through SRP or in combination with lasers. These conflicting results may be due to methodological differences, mainly in relation to the protocols of laser used and to the different irradiation parameters used.
Among the limitations of the study, we can mention the fact of being carried out in animals, and it is not prudent to extrapolate the results to the human species, for further studies in the literature would be necessary.
Conclusion
Within the limits of this study, we can conclude that LLLT was effective as adjuvant treatment for SRP protecting against the occurrence of oxidative tissue damages as well as reducing alveolar bone loss in experimentally induced periodontitis simvastatinmodified rats.
